大行評級 | 大和:重申中國財險(2328.HK)買入評級 目標價升至8.4港元
格隆匯11月1日丨大和發表研究報告,指截止2021年9月內地啓動車險自由定價後已經過一整年,中國財險(2328.HK)業績充分反映了改革的影響。總體而言,中國財險所受到影響比整個行業要溫和得多。
該行指出,公司第三季度的汽車綜合成本比率(CoR)按年提高0.8個百分點。管理層表示,每輛車的保費在第三季度已由從前幾個季度的大幅下滑中穩定下來。該行重申“買入”評級,並將目標價由8.2港元升至8.4港元。該行將今年每股盈利下調3%,但將2022-23年每股盈利上調7%,以反映今年投資收益較低,以及2022-23年車險業務CoR較佳。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.